1. Pharmacotherapy for Diabetic Coronary Disease:

5. Trials Targeting Lower HbA1c Levels

6. VADT: CV Risk Factor Control

8. Look AHEAD: Lifestyle Intervention Did Not Reduce Hard End Points

12. UKPDS: Metformin and Outcomes in New T2D at 36 Months

13. ADVANCE: Reducing HbA1c Lowers Microvascular Events

14. VADT: Intensive Treatment Reduces CVD Events in Cases With Lower Calcified Coronary Atherosclerosis

15. Look AHEAD: Earlier Intervention Beneficial?

16. SAVOR-TIMI 53 and EXAMINE: Conclusions

17. Changes in Microalbuminuria

18. Baseline NT-proBNP and Hospitalization for Heart Failure

19. SAVOR-TIMI 53: Hypoglycemia

20. SAVOR-TIMI 53: Hypoglycemia by Baseline Medication and HbA1c

21. ORIGIN: Severe Hypoglycemia and Outcome

22. ACCORD: Hypoglycemia and Mortality Worse in Standard Group

23. ESC/EASD Guidelines: Glycemic Control in Diabetes

24. ESC/EASD Guidelines: Glycemic Control in Diabetes

25. In Summary

26. Abbreviations

27. Abbreviations (cont)

28. Abbreviations (cont)

29. References

30. References (cont)

31. References (cont)

32. References (cont)

33. References (cont)

34. References (cont)